» Articles » PMID: 28979439

Mesenchymal Stromal Cells for Treatment of the Acute Respiratory Distress Syndrome: The Beginning of the Story

Overview
Publisher Sage Publications
Specialty Critical Care
Date 2017 Oct 6
PMID 28979439
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In spite of decades of research, the acute respiratory distress syndrome (ARDS) continues to have an unacceptably high mortality and morbidity. Mesenchymal stromal cells (MSCs) present a promising candidate for the treatment of this condition and have demonstrated benefit in preclinical models. MSCs, which are a topic of growing interest in many inflammatory disorders, have already progressed to early phase clinical trials in ARDS. While a number of their mechanisms of effect have been elucidated, a better understanding of the complex actions of these cells may pave the way for MSC modifications, which might enable more effective translation into clinical practice.

Citing Articles

Stem Cell-based therapies for COVID-19-related acute respiratory distress syndrome.

Ngai H, Kim D, Hammad M, Gutova M, Aboody K, Cox C J Cell Mol Med. 2022; 26(9):2483-2504.

PMID: 35426198 PMC: 9077311. DOI: 10.1111/jcmm.17265.


Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair.

Fergie N, Todd N, McClements L, McAuley D, OKane C, Krasnodembskaya A FASEB J. 2019; 33(4):5585-5598.

PMID: 30649987 PMC: 6436662. DOI: 10.1096/fj.201802056R.

References
1.
Tilg H, Trehu E, Atkins M, Dinarello C, Mier J . Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 1994; 83(1):113-8. View

2.
Hakki S, Kayis S, Hakki E, Bozkurt S, Duruksu G, Unal Z . Comparison of mesenchymal stem cells isolated from pulp and periodontal ligament. J Periodontol. 2014; 86(2):283-91. DOI: 10.1902/jop.2014.140257. View

3.
Liu H, Liu S, Li Y, Wang X, Xue W, Ge G . The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PLoS One. 2012; 7(4):e34608. PMC: 3325280. DOI: 10.1371/journal.pone.0034608. View

4.
Gupta N, Krasnodembskaya A, Kapetanaki M, Mouded M, Tan X, Serikov V . Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia. Thorax. 2012; 67(6):533-9. PMC: 3358432. DOI: 10.1136/thoraxjnl-2011-201176. View

5.
Saller M, Prall W, Docheva D, Schonitzer V, Popov T, Anz D . Increased stemness and migration of human mesenchymal stem cells in hypoxia is associated with altered integrin expression. Biochem Biophys Res Commun. 2012; 423(2):379-85. DOI: 10.1016/j.bbrc.2012.05.134. View